etravirine and HIV
etravirine has been researched along with HIV in 27 studies
Research
Studies (27)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (37.04) | 29.6817 |
2010's | 15 (55.56) | 24.3611 |
2020's | 2 (7.41) | 2.80 |
Authors
Authors | Studies |
---|---|
De Clercq, E; Du, D; Liu, H; Liu, X; Pannecouque, C; Rai, D; Tian, Y; Wang, L; Zhan, P | 1 |
Elgaher, WA; Hartmann, RW; Haupenthal, J; Mély, Y; Pires, M; Real, E; Saladini, F; Sharma, KK | 1 |
Chen, FE; Gu, SX; Liu, GY; Meng, G; Pannecouque, C; Tang, JF; Wu, FS; Xiao, T; Xu, ZQ; Zhu, YY | 1 |
De Clercq, E; Gao, P; Liu, X; Pannecouque, C; Song, S; Sun, L; Wang, Z; Zhan, P; Zhang, J | 1 |
Challenger, E; Clotet, B; Curran, A; Khoo, S; Miranda, C; Moltó, J; Ribera, E; Santos, JR; Valle, M | 1 |
Kichula, E; Lynch, DR; Schadt, K | 1 |
Borghetti, A; D'Avino, A; De Luca, A; Del Puente, F; Di Biagio, A; Irene Bonelli, S; Riccardi, N; Taramasso, L; Zazzi, M | 1 |
DeMasi, R; Kakuda, TN; Mohammed, P; van Delft, Y | 1 |
Bell, CS; Contreras, GA; Del Bianco, GP; Heresi, GP; Kleinosky, MT; Murphy, JR; Pérez, N | 1 |
Aldieri, C; Bonora, S; Calcagno, A; Carbone, A; Castagna, A; D'Avolio, A; Di Perri, G; Ghisetti, V; Marinaro, L; Nozza, S; Trentalange, A | 1 |
Bañón, S; Casado, JL; Moreno, A; Moreno, S; Rodriguez, MA | 1 |
Belkhir, L; Capron, A; De Laveleye, M; Delongie, KA; Elens, L; Haufroid, V; Vandercam, B; Vincent, A; Yombi, J; Zech, F | 1 |
Cartledge, JD; Lascar, M | 1 |
Couzigou, C; Escaut, L; Morand-Joubert, L; Roque-Afonso, AM; Seang, S; Vittecoq, D | 1 |
García Deltoro, M | 1 |
Sanne, I; Stevens, WS; Venter, F; Wallis, CL | 1 |
Antinori, A; Ceccherini-Silberstein, F; Cozzi-Lepri, A; Monforte, Ad; Mussini, C; Palamara, G; Perno, CF; Santoro, MM; Spagnuolo, V; Zaccarelli, M | 1 |
Arribas, JR | 1 |
Castagna, A; De Wit, S; Florence, E; Hill, A; Marks, S; Ribera, E; van Delft, Y; Vanaken, H | 1 |
Aleixo, AW; Arruda, MB; de M Brindeiro, R; Greco, DB; Martins, AN; Pires, AF; Tanuri, A | 1 |
Durant, J; Duvivier, C; Fätkenheuer, G; Hill, A; Marks, S; Rey, D; Rieger, A; Schmidt, W; van Delft, Y | 1 |
Dilanchian, P; Jayaweera, D | 1 |
Nelson, MR; Waters, L | 1 |
Alcorn, K | 1 |
Geretti, AM | 1 |
Stephenson, J | 1 |
Reviews
6 review(s) available for etravirine and HIV
Article | Year |
---|---|
New protease inhibitors and non-nucleoside reverse transcriptase inhibitors.
Topics: Clinical Trials as Topic; Darunavir; Drug Resistance, Viral; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Nitriles; Pyridazines; Pyridines; Pyrimidines; Pyrones; Sulfonamides; Treatment Outcome | 2008 |
[Resistance to darunavir].
Topics: Adult; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Darunavir; Dose-Response Relationship, Drug; Drug Resistance, Viral; Female; HIV; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Lopinavir; Male; Multicenter Studies as Topic; Mutagenesis, Site-Directed; Mutation, Missense; Nitriles; Phenotype; Point Mutation; Pyridazines; Pyrimidines; Pyrimidinones; Randomized Controlled Trials as Topic; Sulfonamides | 2008 |
Drugs in traditional drug classes (nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor/protease inhibitors) with activity against drug-resistant virus (tipranavir, darunavir, etravirine).
Topics: Anti-HIV Agents; Darunavir; Drug Resistance, Viral; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Nitriles; Pyridazines; Pyridines; Pyrimidines; Pyrones; Ritonavir; Sulfonamides | 2009 |
New therapeutic landscape of NNRTIs for treatment of HIV: a look at recent data.
Topics: Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Drug Resistance, Viral; HIV; HIV Infections; Humans; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Rilpivirine | 2012 |
New drugs.
Topics: Anti-HIV Agents; Benzophenones; Cytidine Triphosphate; Darunavir; Deoxycytidine; Emtricitabine; HIV; HIV Fusion Inhibitors; HIV Reverse Transcriptase; Humans; Imidazoles; Nitriles; Protease Inhibitors; Pyridazines; Pyridines; Pyrimidines; Pyrones; Reverse Transcriptase Inhibitors; Sulfonamides; Sulfur Compounds; Zalcitabine | 2005 |
Resistance testing methodologies and mechanisms of resistance.
Topics: Adenine; Anti-HIV Agents; CCR5 Receptor Antagonists; Drug Resistance, Viral; HIV; Humans; Lopinavir; Nitriles; Organophosphonates; Pyridazines; Pyrimidines; Pyrimidinones; Tenofovir | 2007 |
Trials
4 trial(s) available for etravirine and HIV
Article | Year |
---|---|
Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Cobicistat; Cohort Studies; Darunavir; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Nitriles; Pyridazines; Pyrimidines; RNA, Viral; Young Adult | 2018 |
Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial.
Topics: Adult; Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; Cross-Over Studies; Darunavir; Drug Interactions; Ethanolamines; Fluorenes; Healthy Volunteers; HIV; HIV Infections; Humans; Lumefantrine; Malaria; Middle Aged; Nitriles; Pyridazines; Pyrimidines; Ritonavir; Sulfonamides | 2013 |
HIV RNA suppression rates after 24 weeks of treatment with etravirine, darunavir/ritonavir and raltegravir in the etravirine early access programme.
Topics: Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; Darunavir; Drug Administration Schedule; Female; HIV; HIV Infections; Humans; Immunosuppression Therapy; Male; Middle Aged; Nitriles; Pyridazines; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Sulfonamides; Treatment Outcome | 2010 |
Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Double-Blind Method; Female; HIV; HIV Infections; Humans; Lipids; Male; Middle Aged; Nitriles; Placebos; Pyridazines; Pyrimidines; Viral Load; Young Adult | 2012 |
Other Studies
17 other study(ies) available for etravirine and HIV
Article | Year |
---|---|
Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives.
Topics: Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Design; Heterocyclic Compounds; HIV; HIV Reverse Transcriptase; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Nitrogen; Pyrazoles; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2014 |
Discovery and Structure-Based Optimization of 2-Ureidothiophene-3-carboxylic Acids as Dual Bacterial RNA Polymerase and Viral Reverse Transcriptase Inhibitors.
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Carboxylic Acids; DNA-Directed RNA Polymerases; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Escherichia coli; HEK293 Cells; HeLa Cells; HIV; Humans; Microbial Sensitivity Tests; Molecular Structure; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Thiophenes | 2016 |
Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activities.
Topics: Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Design; HIV; HIV Reverse Transcriptase; Humans; Indazoles; Microbial Sensitivity Tests; Molecular Structure; Piperidines; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2020 |
Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs.
Topics: Anti-HIV Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; HIV; HIV Reverse Transcriptase; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2021 |
Etravirine in Friedreich's ataxia: Lessons from HIV?
Topics: Drug Repositioning; Friedreich Ataxia; HIV; Humans; Nitriles; Pyridazines; Pyrimidines | 2019 |
Is it time to re-think the use of etravirine in patients with available genotypic resistance test?
Topics: HIV; HIV Infections; Humans; Nitriles; Pyridazines; Pyrimidines; Sweden | 2019 |
Prevalence and risk factors associated with resistance-associated mutations to etravirine in a cohort of perinatally HIV-infected children.
Topics: Anti-HIV Agents; Child; Child, Preschool; Cohort Studies; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Male; Mutation, Missense; Nitriles; Prevalence; Pyridazines; Pyrimidines; Retrospective Studies; Risk Factors | 2013 |
Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients.
Topics: Adult; CD4 Lymphocyte Count; Female; HIV; HIV Infections; Humans; Male; Middle Aged; Nitriles; Plasma; Pyridazines; Pyrimidines; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load | 2014 |
Efficacy and pharmacokinetics of the combination of etravirine plus raltegravir as novel dual antiretroviral maintenance regimen in HIV-infected patients.
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Follow-Up Studies; HIV; HIV Infections; Humans; Male; Middle Aged; Nitriles; Prospective Studies; Pyridazines; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Viral Load | 2015 |
Quantification of darunavir and etravirine in human peripheral blood mononuclear cells using high performance liquid chromatography tandem mass spectrometry (LC-MS/MS), clinical application in a cohort of 110 HIV-1 infected patients and evidence of a pote
Topics: Biomarkers; Chromatography, High Pressure Liquid; Cohort Studies; Darunavir; Drug Interactions; Drug Monitoring; Female; Follow-Up Studies; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Leukocytes, Mononuclear; Limit of Detection; Male; Middle Aged; Nitriles; Prognosis; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Tandem Mass Spectrometry | 2016 |
Efficacy of etravirine for treatment of acute HIV meningoencephalitis.
Topics: Adult; Anti-HIV Agents; Cerebrospinal Fluid; Female; Hepatitis C; HIV; HIV Infections; Humans; Meningoencephalitis; Nitriles; Pyridazines; Pyrimidines; Treatment Outcome | 2009 |
Will etravirine work in patients failing nonnucleoside reverse transcriptase inhibitor-based treatment in southern Africa?
Topics: Africa, Southern; Drug Resistance, Viral; HIV; HIV Infections; Humans; Mutation; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Treatment Failure | 2009 |
Is there any potential for first-line etravirine use? Analysis from a large data set of antiretroviral therapy-naive HIV-infected patients undergoing resistance test.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Male; Middle Aged; Mutation; Nitriles; Pyridazines; Pyrimidines; Young Adult | 2010 |
Prevalence of etravirine-associated mutations in clinical samples with genotypic resistance to nevirapine and efavirenz in Brazilian clinics.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Brazil; Cyclopropanes; Drug Resistance, Viral; HIV; HIV Infections; Humans; Mutation, Missense; Nevirapine; Nitriles; Prevalence; Pyridazines; Pyrimidines | 2011 |
TMC 125 possibly effective against NNRTI-resistant HIV.
Topics: Drug Resistance, Viral; HIV; HIV Infections; Humans; Mutation; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Virus Replication | 2004 |
TMC125 study highlights failing NNRTI regimen task.
Topics: Clinical Trials, Phase II as Topic; Drug Resistance, Viral; HIV; Humans; Mutation; Nitriles; Pyridazines; Pyrimidines; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Viral Load | 2006 |
Researchers explore new anti-HIV agents.
Topics: Anti-HIV Agents; CCR5 Receptor Antagonists; Clinical Trials as Topic; Cyclic N-Oxides; Drugs, Investigational; Enfuvirtide; Furans; HIV; HIV Envelope Protein gp120; HIV Envelope Protein gp41; HIV Infections; HIV Integrase Inhibitors; Humans; Nitriles; Oximes; Peptide Fragments; Piperazines; Piperidines; Pyridazines; Pyridines; Pyrimidines; Reverse Transcriptase Inhibitors; Triazoles | 2002 |